BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 26733179)

  • 21. ZEB2 mediates multiple pathways regulating cell proliferation, migration, invasion, and apoptosis in glioma.
    Qi S; Song Y; Peng Y; Wang H; Long H; Yu X; Li Z; Fang L; Wu A; Luo W; Zhen Y; Zhou Y; Chen Y; Mai C; Liu Z; Fang W
    PLoS One; 2012; 7(6):e38842. PubMed ID: 22761708
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F.
    Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM
    Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene Bmi1.
    Tu Y; Gao X; Li G; Fu H; Cui D; Liu H; Jin W; Zhang Y
    Cancer Res; 2013 Oct; 73(19):6046-55. PubMed ID: 23950210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1.
    Guo H; Nan Y; Zhen Y; Zhang Y; Guo L; Yu K; Huang Q; Zhong Y
    Tumour Biol; 2016 Oct; 37(10):13751-13761. PubMed ID: 27476171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of Roundabout4 predicts poor prognosis of primary glioma patients via correlating with microvessel density.
    Cai H; Xue Y; Liu W; Li Z; Hu Y; Li Z; Shang X; Liu Y
    J Neurooncol; 2015 May; 123(1):161-9. PubMed ID: 25859844
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ProBDNF and its receptors are upregulated in glioma and inhibit the growth of glioma cells in vitro.
    Xiong J; Zhou L; Yang M; Lim Y; Zhu YH; Fu DL; Li ZW; Zhong JH; Xiao ZC; Zhou XF
    Neuro Oncol; 2013 Aug; 15(8):990-1007. PubMed ID: 23576602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-520c inhibits glioma cell migration and invasion by the suppression of transforming growth factor-β receptor type 2.
    Hu S; Chen H; Zhang Y; Wang C; Liu K; Wang H; Luo J
    Oncol Rep; 2017 Mar; 37(3):1691-1697. PubMed ID: 28184932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Jumonji AT-rich interactive domain 1B overexpression is associated with the development and progression of glioma.
    Fang L; Zhao J; Wang D; Zhu L; Wang J; Jiang K
    Int J Mol Med; 2016 Jul; 38(1):172-82. PubMed ID: 27246838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of SRPK1 in gliomas and its role in glioma cell lines viability.
    Sigala I; Tsamis KI; Gousia A; Alexiou G; Voulgaris S; Giannakouros T; Kyritsis AP; Nikolakaki E
    Tumour Biol; 2016 Jul; 37(7):8699-707. PubMed ID: 26738865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gelsolin promotes cell growth and invasion through the upregulation of p-AKT and p-P38 pathway in osteosarcoma.
    Ma X; Sun W; Shen J; Hua Y; Yin F; Sun M; Cai Z
    Tumour Biol; 2016 Jun; 37(6):7165-74. PubMed ID: 26662962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of MACC1 on human malignant glioma progression and patients' unfavorable prognosis.
    Hagemann C; Fuchs S; Monoranu CM; Herrmann P; Smith J; Hohmann T; Grabiec U; Kessler AF; Dehghani F; Löhr M; Ernestus RI; Vince GH; Stein U
    Neuro Oncol; 2013 Dec; 15(12):1696-709. PubMed ID: 24220141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma.
    Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X
    Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
    Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
    Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrated transcriptomic and computational analysis for biomarker identification in human glioma.
    Xing W; Zeng C
    Tumour Biol; 2016 Jun; 37(6):7185-92. PubMed ID: 26663173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of hSNF2H in glioma promotes cell proliferation, invasion, and chemoresistance through its interaction with Rsf-1.
    Zhao XC; An P; Wu XY; Zhang LM; Long B; Tian Y; Chi XY; Tong DY
    Tumour Biol; 2016 Jun; 37(6):7203-12. PubMed ID: 26666816
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Migration-prone glioma cells show curcumin resistance associated with enhanced expression of miR-21 and invasion/anti-apoptosis-related proteins.
    Yeh WL; Lin HY; Huang CY; Huang BR; Lin C; Lu DY; Wei KC
    Oncotarget; 2015 Nov; 6(35):37770-81. PubMed ID: 26473373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-320a suppresses in GBM patients and modulates glioma cell functions by targeting IGF-1R.
    Guo T; Feng Y; Liu Q; Yang X; Jiang T; Chen Y; Zhang Q
    Tumour Biol; 2014 Nov; 35(11):11269-75. PubMed ID: 25117070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.
    Ding Z; Liu X; Liu Y; Zhang J; Huang X; Yang X; Yao L; Cui G; Wang D
    Mol Carcinog; 2015 May; 54(5):405-15. PubMed ID: 24347226
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ZNF326 promotes malignant phenotype of glioma by up-regulating HDAC7 expression and activating Wnt pathway.
    Yu X; Wang M; Wu J; Han Q; Zhang X
    J Exp Clin Cancer Res; 2019 Jan; 38(1):40. PubMed ID: 30691485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ING5 inhibits cancer aggressiveness via preventing EMT and is a potential prognostic biomarker for lung cancer.
    Zhang F; Zhang X; Meng J; Zhao Y; Liu X; Liu Y; Wang Y; Li Y; Sun Y; Wang Z; Mei Q; Zhang T
    Oncotarget; 2015 Jun; 6(18):16239-52. PubMed ID: 25938545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.